Improving Cancer Pain Management Through Teach-Back Educational Approach for Patients and Primary Caregivers: A Pilot Study
NCT ID: NCT05856292
Last Updated: 2023-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2022-03-01
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Patient Education and Cancer Pain
NCT02391740
Effectiveness of the Digital Multimedia Health Education in Improving Cancer Pain, Analgesic Adherence, and Pain Control Satisfaction With Cancer Patient
NCT06791213
Pain Education to Improve Cancer Pain Management Patients
NCT03205579
Effectiveness of a Patient Therapeutic Education Program in Improving Pain Management
NCT03297723
Educational Intervention Targeting Nurses Attitudes and Knowledge About Cancer-related Pain Management
NCT01313234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Teach-back method, where patients and family caregivers are asked to repeat the instruction they've received from their health care professionals, can assess patients' understanding, repeat or modify the educational material if comprehension is not demonstrated. This pilot study compared the addition of the Teach-back method for cancer patients and their caregivers and its relation to cancer pain management.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Teach-Back
The intervention group were educated using the standard educational method with the addition of Teach-back enhancement. It consists of 5 steps: Triage, Tools, Take Responsibility, Tell Me, and Try Again. The Triage, Tools, and Try Again focus on effective information delivery, while the Take Responsibility and Tell Me evaluate the patient's ability to receive the information
Teach Back
Standard cancer pain educational intervention enhanced with teach-back method
Non-Teach-Back
No educational intervention, just standard educational methods
Placebo
Standard cancer pain educational intervention without enhancement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Teach Back
Standard cancer pain educational intervention enhanced with teach-back method
Placebo
Standard cancer pain educational intervention without enhancement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥18 years old
* Signed the informed consent
* Willing to cooperate until the end of studies
* The patient is fully conscious and able to communicate well
* Cared by a family caregiver
* Family caregiver able to fully function as a caregiver
Exclusion Criteria
* Not willing to cooperate until the end of studies
* Altered mental status and communication difficulties
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tarumanagara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ricky Dosan
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dharmais National Cancer Centre
Jakarta, , Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TarumanagaraU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.